Clinical Trial Update: RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients

View source ↗

Summary

A non-interventional study evaluating the effectiveness of RAYALDEE (paricalcitol) in non-dialysis CKD patients with secondary hyperparathyroidism has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Rayaldee (calcifediol)

Snippet

Sponsor: Vifor (International) Inc. | Conditions: Chronic Kidney Disease | Status: COMPLETED